News

  • 28 November 2011

    Sclerosis drug could slow eye cancer growth

    A drug used to treat amyotrophic lateral sclerosis, a form of motor neurone disease, has been shown to make eye tumours less likely to grow if they spread to other...

  • 27 November 2011

    Summit SMT C1100 secures FDA orphan drug status

    UK-based drug discovery company Summit has received the US Food & Drug Administration's (FDA) orphan drug status for SMT C1100, used to treat Duchenne muscular dystrophy.

  • 24 November 2011

    Pfizer to buy Excaliard Pharmaceuticals

    Pfizer has entered into a definitive agreement to acquire Excaliard Pharmaceuticals, gaining access to EXC 001, a skin scarring treatment.

  • 24 November 2011

    UK switches HPV vaccine supplier

    The UK will switch to using Merck's Gardasil vaccine instead of GlaxoSmithKline's rival product Cervarix to prevent girls from contracting the HPV virus, which can cause cervical cancer.

Close
Close
Close

Go Top